Literature DB >> 24059370

Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.

Kyung Won Kim1, Katherine M Krajewski, Mizuki Nishino, Jyothi P Jagannathan, Atul B Shinagare, Sree Harsha Tirumani, Nikhil H Ramaiya.   

Abstract

OBJECTIVE: The purposes of this article are to review the current management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) based on the 2012 National Comprehensive Cancer Network guidelines and to describe the role of imaging in a multidisciplinary approach.
CONCLUSION: The management of GEP-NETs has become complex, requiring a multidisciplinary approach. The World Health Organization classification of GEP-NETs has been revised; the U.S. Food and Drug Administration has approved molecular targeted agents (sunitinib, everolimus) for the treatment of pancreatic NETs; and the National Comprehensive Cancer Network clinical practice guidelines have been updated.

Entities:  

Mesh:

Year:  2013        PMID: 24059370      PMCID: PMC3970265          DOI: 10.2214/AJR.12.10240

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  35 in total

Review 1.  Carcinoid tumors of the small bowel: a multitechnique imaging approach.

Authors:  Karen M Horton; Ihab Kamel; Lawrence Hofmann; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2004-03       Impact factor: 3.959

2.  Pancreatic neuroendocrine neoplasms: diagnosis and management.

Authors:  Aparna Balachandran; Eric P Tamm; Priya R Bhosale; Madhavi Patnana; Raghu Vikram; Jason B Fleming; Matthew H Katz; Chuslip Charnsangavej
Journal:  Abdom Imaging       Date:  2013-04

Review 3.  What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents.

Authors:  Sona A Chikarmane; Bharti Khurana; Katherine M Krajewski; Atul B Shinagare; Stephanie Howard; Aaron Sodickson; Jyothi Jagannathan; Nikhil Ramaiya
Journal:  Emerg Radiol       Date:  2012-06-07

4.  Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know.

Authors:  Stephanie Anne Holler Howard; Katherine M Krajewski; Eavan Thornton; Jyothi P Jagannathan; Kevin O'Regan; James Cleary; Nikhil Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

Review 5.  Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.

Authors:  L Albiges; F Chamming's; B Duclos; M Stern; R J Motzer; A Ravaud; P Camus
Journal:  Ann Oncol       Date:  2012-06-11       Impact factor: 32.976

6.  Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.

Authors:  Justin R Parekh; Sam C Wang; Emily K Bergsland; Alan P Venook; Robert S Warren; Grace E Kim; Eric K Nakakura
Journal:  Pancreas       Date:  2012-08       Impact factor: 3.327

7.  Neuroendocrine tumors.

Authors:  Matthew H Kulke; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Michael A Choti; Orlo H Clark; Gerard M Doherty; James Eason; Lyska Emerson; Paul F Engstrom; Whitney S Goldner; Martin J Heslin; Fouad Kandeel; Pamela L Kunz; Boris W Kuvshinoff; Jeffrey F Moley; Venu G Pillarisetty; Leonard Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata; Jonathan R Strosberg; Jean-Nicolas Vauthey; Rebekah White; James C Yao; Deborah A Freedman-Cass; Mary A Dwyer
Journal:  J Natl Compr Canc Netw       Date:  2012-06-01       Impact factor: 11.908

Review 8.  Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.

Authors:  Anders Sundin; Andrea Rockall
Journal:  Neuroendocrinology       Date:  2012-10-12       Impact factor: 4.914

Review 9.  Endocrine tumors of the gut and pancreas tumor biology and classification.

Authors:  G Rindi; G Klöppel
Journal:  Neuroendocrinology       Date:  2004       Impact factor: 4.914

Review 10.  Liver metastases in the era of molecular targeted therapy: new faces of treatment response.

Authors:  Atul Bhanudas Shinagare; Jyothi P Jagannathan; Katherine M Krajewski; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-07       Impact factor: 3.959

View more
  14 in total

Review 1.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Authors:  James R Howe; Kenneth Cardona; Douglas L Fraker; Electron Kebebew; Brian R Untch; Yi-Zarn Wang; Calvin H Law; Eric H Liu; Michelle K Kim; Yusuf Menda; Brian G Morse; Emily K Bergsland; Jonathan R Strosberg; Eric K Nakakura; Rodney F Pommier
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

2.  Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.

Authors:  Dong Wook Kim; Hyoung Jung Kim; Kyung Won Kim; Jae Ho Byun; Ki Byung Song; Ji Hoon Kim; Seung-Mo Hong
Journal:  Eur Radiol       Date:  2014-12-03       Impact factor: 5.315

3.  Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Authors:  Scott Paulson; David Ray; Sharan Aranha; Amy Scales; Yunfei Wang; Eric Liu
Journal:  Oncol Ther       Date:  2022-09-22

4.  Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors.

Authors:  Yijing Xie; Shipeng Zhang; Xianwang Liu; Xiaoyu Huang; Qing Zhou; Yongjun Luo; Qian Niu; Junlin Zhou
Journal:  Jpn J Radiol       Date:  2022-03-14       Impact factor: 2.701

5.  Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.

Authors:  Dong Wook Kim; Hyoung Jung Kim; Kyung Won Kim; Jae Ho Byun; So Yeon Kim; Ki Byung Song; Nikhil H Ramaiya; Sree Harsha Tirumani; Seung-Mo Hong
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

6.  Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes.

Authors:  Emily B Ehlerding; Shreya Goel; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-08       Impact factor: 9.236

Review 7.  Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.

Authors:  Sundeep Malla; Pawan Kumar; Kumble Seetharama Madhusudhan
Journal:  Abdom Radiol (NY)       Date:  2020-09-22

Review 8.  [Neuroendocrine tumors of the abdomen].

Authors:  M Juchems
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

9.  Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine.

Authors:  Andrzej Smereczyński; Teresa Starzyńska; Katarzyna Kołaczyk
Journal:  J Ultrason       Date:  2015-09-30

10.  Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors.

Authors:  X Merino-Casabiel; J Aller; J Arbizu; R García-Figueiras; C González; E Grande; P Jiménez-Fonseca; M I Sevilla; J Capdevila
Journal:  Clin Transl Oncol       Date:  2018-05-15       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.